Axa’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-44,200
Closed -$1.86M 1180
2023
Q2
$1.86M Buy
44,200
+18,900
+75% +$764K 0.01% 741
2023
Q1
$901K Buy
+25,300
New +$918K ﹤0.01% 882
2022
Q3
Sell
-9,050
Closed -$649K 1227
2022
Q2
$649K Sell
9,050
-5,050
-36% -$369K ﹤0.01% 938
2022
Q1
$1.14M Sell
14,100
-5,000
-26% -$423K ﹤0.01% 931
2021
Q4
$1.96M Buy
19,100
+15,200
+390% +$1.46M 0.01% 849
2021
Q3
$341K Sell
3,900
-1,500
-28% -$136K ﹤0.01% 1119
2021
Q2
$483K Sell
5,400
-600
-10% -$50.7K ﹤0.01% 1110
2021
Q1
$455K Sell
6,000
-94,300
-94% -$7.11M ﹤0.01% 1088
2020
Q4
$6.83M Buy
100,300
+5,200
+5% +$324K 0.02% 622
2020
Q3
$5.06M Buy
95,100
+79,200
+498% +$4.72M 0.02% 619
2020
Q2
$926K Sell
15,900
-700
-4% -$37.6K ﹤0.01% 969
2020
Q1
$654K Sell
16,600
-3,500
-17% -$205K ﹤0.01% 929
2019
Q4
$1.2M Sell
20,100
-91,900
-82% -$4.94M ﹤0.01% 865
2019
Q3
$5.96M Sell
112,000
-1,800
-2% -$92.4K 0.02% 593
2019
Q2
$5.81M Buy
+113,800
New +$5.3M 0.02% 603

Other funds holding SYNH

Axa's SYNH Position: Q3 2023 in Review

Axa sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 44,200 shares — an estimated $1.86M sold.

Axa first reported a position in SYNH in Q2 2019 and held it in 15 quarters. The position peaked at $6.83M in Q4 2020. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Axa reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Axa sold 44,200 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $1.86M.
  • Axa first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2019 and held it in 15 quarters.
  • Axa's Syneos Health, Inc. Class A Common Stock position peaked at $6.83M in Q4 2020.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Axa's 13F filing for Q3 2023, filed 14 Nov 2023.